IN-DATE
5015005: NuVasive Attrax Putty Biotextured Bone Graft Substitute, 50mm x 12.5mm x 4mm, 5cc Strip (Pack of 2)
Sign in to add this product to your favorites!
| Price: | $899.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 03-2028 |
| Express: | Need it tomorrow? Order in next 2 hours 0 minutes and choose overnight shipping at checkout. |
Additional Details
NuVasive Attrax Putty Biotextured Bone Graft Substitute
The AttraX® ceramic surface has unique microstructure and microporosity that are optimized for bone formation. The unique microarchitecture of AttraX drives the differentiation of mesenchymal stem cells (MSCs) into bone-forming osteoblasts without added growth factors
Alkylene Oxide Copolymer (AOC) Carrier
- Selected for its ability to be molded into a variety of shapes for intraoperative flexibility
- Eliminated from the body within 48 hours
- Doesn’t interfere with bone healing process
Additional Details
- Company Name: Nuvasive, Inc
- FDA Product Code: MQV
- FDA Product Code Name: Filler, Bone Void, Calcium Compound
- GMDN Term Code: 17751
- GMDN Term Name: Bone matrix implant, synthetic, non-antimicrobial
- GMDN Term Definition: A bioabsorbable device made of synthetic material intended to be implanted into the body to provide osteoconductive bone-tissue scaffolds, and sometimes osteovascularization, to replace bone lost through trauma, surgery, or pathological conditions (e.g., osteoporosis); it does not include an antimicrobial agent(s). It may be made of ceramics (e.g., tricalcium phosphate or hydroxyapatite), bioactive glasses/minerals/metals (e.g., strontium), or bioabsorbable polymers. It is used to fill cystic defects, repair fractures, and/or extend autogenous bone grafts and is typically provided as cancellous blocks, chips, or granules of varying sizes, or mouldable/fluid materials.
AccessGUDID Info
- FDA Product Code: MQV
- FDA Product Code Name: FILLER, BONE VOID, CALCIUM COMPOUND
- GMDN Term Code: 17751
- GMDN Term Name: Bone matrix implant, synthetic, non-antimicrobial
- GMDN Term Description: A bioabsorbable device made of synthetic material intended to be implanted into the body to provide osteoconductive bone-tissue scaffolds, and sometimes osteovascularization, to replace bone lost through trauma, surgery, or pathological conditions (e.g., osteoporosis); it does not include an antimicrobial agent(s). It may be made of ceramics (e.g., tricalcium phosphate or hydroxyapatite), bioactive glasses/minerals/metals (e.g., strontium), or bioabsorbable polymers. It is used to fill cystic defects, repair fractures, and/or extend autogenous bone grafts and is typically provided as cancellous blocks, chips, or granules of varying sizes, or mouldable/fluid materials.
Manufacturer
NuVasive is a leading medical device company specializing in spinal surgery and minimally invasive procedures. Their product portfolio includes spinal implants, surgical instruments, and biologics designed to improve patient outcomes in spinal deformity, degenerative disc disease, and surgical reconstruction. Key innovations from NuVasive include the XLIF (eXtreme Lateral Interbody Fusion) platform, which offers a minimally invasive approach to spine surgery, as well as their Reline and Modulus systems, which provide advanced fixation and instrumentation for spinal surgeries.
Globus Medical is another prominent player in the spine surgery space, offering a wide range of minimally invasive and robotic technologies for the treatment of spinal disorders. Globus specializes in spinal fusion devices, motion preservation implants, and robotic-assisted surgery systems, such as the ExcelsiusGPS robotic platform, which enhances the precision of spinal procedures. With an emphasis on surgical innovation, Globus provides advanced solutions that improve both clinical outcomes and patient safety in spinal surgery.
Both companies are known for their cutting-edge technologies that support spinal surgeons in achieving optimal patient results with reduced recovery times and less invasive procedures.
